Viral Vaccines Market Size, Share & COVID-19 Impact Analysis, By Form (Liquid and Lyophilized), By Container Format (Vials and Prefilled Syringes), By Biosafety Level Type (Biosafety Level 1, Biosafety Level 2, Biosafety Level 3, and Biosafety Level 4), and Regional Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI107531

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 4.4% from 2023 to 2030
Unit	Value (USD Billion)
Segmentation	By Form Liquid Lyophilized
	By Container Format Vials Prefilled Syringes
	By Biosafety Level Type Biosafety Level 1 Biosafety Level 2 Biosafety Level 3 Biosafety Level 4
	By Region North America (By Form, Container Format, Biosafety Level Type, and Country) U.S. Canada Europe (By Form, Container Format, Biosafety Level Type, and Country/Sub-Region) U.K. Germany France Italy Spain Scandinavia Rest of Europe Asia Pacific (By Form, Container Format, Biosafety Level Type, and Country/Sub-Region) Japan China India Australia South Korea Rest of Asia Pacific Rest of the World (By Form, Container Format, and Biosafety Level Type)